Clik here to view.
CaaMTech Publishes Fundamental Research on Aeruginascin Derivatives
In collaboration with the Manke Lab at UMass Dartmouth and the Designer Drug Research Unit (DDRU) at the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP), CaaMTech scientists...
View ArticleClik here to view.
CaaMTech Creates Two New Prodrugs of 4-HO-DiPT
CaaMTech scientists, in collaboration with the Manke Lab at UMass Dartmouth, recently reported their synthesis and structural characterization of two novel prodrugs of 4-HO-DiPT. The scientists...
View ArticleClik here to view.
Psilacetin is More Potent than Psilocybin, Study Shows
A new study comparing the pharmacology of naturally occurring and synthetic psilocybin analogues led by scientists at the Designer Drug Research Unit in the Intramural Research Program of the National...
View ArticleClik here to view.
CaaMTech Synthesizes and Characterizes Monoalkyl Tryptamine 4-HO-NiPT
CaaMTech, in collaboration with scientists from the Manke Lab at UMass Dartmouth, recently published its synthesis and structural characterization of 4-HO-NiPT and several of its precursors. The...
View ArticleClik here to view.
Foundational Science for the Psilocybin Analog 4-PrO-DMT in Mice
Through its Cooperative Research and Development Agreement with the Designer Drug Research Unit at the National Institute on Drug Abuse (NIDA) Intramural Research Program (part of the National...
View ArticleClik here to view.
CaaMTech and University of Massachusetts Dartmouth Collaborate to Research...
Issaquah, WA, August 3, 2023 – CaaMTech, in collaboration with the University of Massachusetts Dartmouth, has published the solid-state structures of N-cyclohexyltryptamine and two of its salts,...
View ArticleClik here to view.
CaaMTech Crystallography Collaboration Clarifies Chemical Characterization...
CaaMTech’s most recent publication, in collaboration with scientists from the Manke Lab at UMass Dartmouth and Dr. Nathan Sacket of the University of Washington Department of Psychiatry &...
View ArticleClik here to view.
CaaMTech CEO to Present at ACS Meeting
CaaMTech CEO, Dr. Andrew Chadeayne, will give two presentations at the 2023 Rocky Mountain Regional Meeting of the American Chemical Society on September 16th. The first presentation will focus on...
View ArticleClik here to view.
CaaMTech Collaboration Investigates Terpene Production in Magic Mushrooms
Scientists at The Leibniz Institute for Natural Product Research and Infection Biology, working in collaboration with CaaMTech, recently reported new results investigating terpene-producing enzymes in...
View ArticleClik here to view.
Dr. Nathan Sackett Joins CaaMTech to Advise on Neuropsychiatry
Dr. Nathan Sackett has joined CaaMTech’s growing team of scientific advisors as a leading expert on addiction psychiatry. Dr. Sackett is an Acting Assistant Professor at the University of Washington...
View Article